Chemotherapy Induced Nausea And Vomiting — Patent Landscape
5
Approved drugs
58
Active US patents
50/100
Avg vulnerability
—
Annual revenue covered
Originators in Chemotherapy Induced Nausea And Vomiting
Merck & Co.
31 patents
Helsinn Hlthcare
12 patents
Hikma
7 patents
GSK (originally Glaxo)
4 patents
Wellhouse Pharma
4 patents
Cliff calendar — next 15 years
4
27
4
28
7
29
10
30
1
31
31
35
1
38
Approved drugs ranked by patent estate
| Drug | Originator | Active patents | Avg vuln | Revenue | First cliff |
|---|---|---|---|---|---|
|
Emend
APREPITANT
|
Merck & Co. | 31 | 60 | — | 2027-09-26 |
|
Akynzeo
NETUPITANT
|
Helsinn Hlthcare | 12 | 47 | — | 2030-11-18 |
|
Reglan
Metoclopramide Hydrochloride
|
Hikma | 7 | 75 | — | 2029-12-22 |
|
Marinol
DRONABINOL
|
Wellhouse Pharma | 4 | 19 | — | 2028-08-06 |
|
Zofran
ondansetron
|
GSK (originally Glaxo) | 4 | 51 | — | 2029-11-23 |
Most attackable patents
| Patent | Drug | Type | Vuln | Expiry |
|---|---|---|---|---|
| 12194009 | Reglan | method of use | 81 | 2029-12-22 |
| 12194008 | Reglan | method of use | 81 | 2029-12-22 |
| 12042494 | Akynzeo | method of use | 81 | 2030-11-18 |
| 8258132 | Emend | method of use | 80 | 2027-09-26 |
| 8258132 | Emend | method of use | 80 | 2027-09-26 |
| 8258132 | Emend | method of use | 80 | 2027-09-26 |
| 11813231 | Reglan | method of use | 76 | 2029-12-22 |
| 11628150 | Reglan | method of use | 76 | 2029-12-22 |
| 11559523 | Akynzeo | method of use | 76 | 2030-11-18 |
| 8258132 | Emend | method of use | 75 | 2027-09-26 |
Strongest defences
| Patent | Drug | Type | Vuln | Expiry |
|---|---|---|---|---|
| 10233154 | Akynzeo | composition of matter | 4 | 2035-09-25 |
| 10676440 | Akynzeo | composition of matter | 4 | 2035-09-25 |
| 10961195 | Akynzeo | composition of matter | 4 | 2035-09-25 |
| 9951016 | Akynzeo | composition of matter | 4 | 2035-09-25 |
| 9345771 | Marinol | composition of matter | 17 | 2028-08-06 |
| 8222292 | Marinol | composition of matter | 17 | 2028-08-06 |
| 10265293 | Marinol | composition of matter | 17 | 2028-08-06 |
| 11253472 | Marinol | composition of matter | 25 | 2028-08-06 |
| 9974793 | Emend | formulation | 42 | 2035-09-18 |
| 10500208 | Emend | formulation | 42 | 2035-09-18 |
Related
- Chemotherapy Induced Nausea And Vomiting — full disease profile
- AI Patent Landscape Report — type "chemotherapy induced nausea and vomiting" for an AI exec memo
- Company Patent Rankings
- Biosimilar Opportunity Scanner